News-Medical.Net on MSN
Identifying common genetic markers for multiple sclerosis
A new study published in Neurology and led by Queen Mary University of London has revealed that people of South Asian, African , and European ancestry share many of the same genetic risk factors for ...
A DNA test could help match patients with psychiatric medications, potentially reducing the long and frustrating trial-and-error process.
An international group of investigators led by scientists at Memorial Sloan Kettering Cancer Center (MSKCC) and the National Cancer Institute has identified a new genetic marker of risk for breast ...
This Collection contains descriptions of sequence, genetic marker, variant, and recombination data relevant to genetics, population genetics and population genomics. Datasets for SNPs, allele ...
ENNA, Italy, 24 June 2025 – In a comprehensive Genomic Press Thought Leaders Invited Review, researchers have synthesized findings from dozens of studies examining how genetic markers for mood ...
An autoimmune disorder that affects the thyroid gland, called autoimmune hypothyroidism (AIHT), is the most common autoimmune disease, yet it remains largely understudied. New research from scientists ...
Brno, Czech Republic - Researchers have identified a genetic marker that not only predisposes patients with diabetes to develop diabetic nephropathy (DN) but also appears to accelerate its development ...
Researchers have discovered a genetic marker that, if present, indicates a significantly increased risk of developing breast cancer. Women with the variation in their DNA are 1.4 times more likely to ...
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity. DNA testing and ...
Genetic variants linked to a rare form of bicuspid aortic valve disease that affects young adults and can lead to dangerous and potentially life-threatening aortic complications have been identified ...
The research team analyzed polygenic scores for C-reactive protein, a key marker of inflammation, in 1059 European patients with major depressive disorder who received at least four weeks of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results